Home HUB Organoids

HUB Organoids

acquired
-
Drug Development Service Provider

Basic Information

Hubrecht Organoid Technology (HUB) was founded by the Hubrecht Institute, University Medical Center Utrecht, and the Royal Netherlands Academy of Arts and Sciences (KNAW) to refine the development of organoids and promote their adoption worldwide. HUB Organoid Technology represents a paradigm shift, bridging the gap between the laboratory and the clinic, and effectively enabling "patients in the lab" scenarios for drug discovery and development, preclinical patient stratification, predictive biomarker discovery, personalized medicine, clinical trials, regenerative medicine, and companion diagnostic applications.
HUB Organoids Holding B.V.
Netherlands
101~500 people
--
info@huborganoids.nl